Cho, Soo-Jin
Song, Tae-Jin
Chu, Min Kyung
Funding for this research was provided by:
Korean Neurological Association
Article History
First Online: 30 May 2019
Compliance with Ethical Standards
:
: Soo-Jin Cho was involved as a site investigator of multicenter trial sponsored by the Otsuka Korea, Eli Lilly and company, and Novartis, worked as an advisory member for Teva, and received research support from the Hallym University Research Fund 2016 and a grant from the Korean Neurological Association (KNA-16-MI-09). Dr. Cho also received personal fees from Allergan Korea and Yuyu Pharmaceutical Company.Tae-Jin Song declares no potential conflicts of interest.Min Kyung Chu was a site investigator for a multicenter trial sponsored by the Otsuka Korea, Novartis International AG, and Eli Lilly and company. He worked as an advisory member for Teva and received lecture honoraria from Allergan Korea, Handok-Teva, and Yuyu Pharmaceutical Company in the past 24 months.
: This article does not contain any studies with human or animal subjects performed by any of the authors.